DURHAM, N.C., JULY 21, 2017 — Premier Research, seeking to accelerate clinical trial design and patient recruitment to better serve its highly innovative customers, has signed an agreement with TriNetX to allow direct query access to its global health research network, comprised of healthcare organizations representing over 84 million patients globally. The Durham-based contract research organization will use TriNetX’s cloud-based platform to determine the impact of eligibility criteria, analyze the cohort’s key data and guide sponsors to focus on real-world eligibility criteria and study expectations.
“Data has always been central to the clinical research process, and it’s becoming even more of a strategic differentiator within the industry as drug development costs keep rising,” said Colin Hayward, Premier Research Chief Medical Officer. “Without clean, decision-ready study data, you don’t have a product. Consequently, you can’t have enough good insight, and you can’t have it soon enough.”
TriNetX will enable Premier Research to analyze patient populations using search criteria that span multiple longitudinal data points. The platform’s advanced analytics identify which criteria have the most impact, and each data point in the network can be traced to the healthcare organizations best able to identify and contribute individual patients — enabling Premier Research to develop the most robust and timely clinical trial strategy.
“Our customers are typically small biotech and specialty pharma companies that are moving fast into areas that demand a higher degree of upfront therapeutic intelligence and accuracy, especially in areas of rare disease and oncology,” said Julie Gauthier, Director of Medical Informatics at Premier Research. “Their data-intensive trials demand a new kind of CRO that has the analytics capacity to keep pace with their complex clinical and therapeutic expertise.”
With direct access to next-level of information, the company will continue offering its customers creative, evidence-based solutions. “We look forward to teaming with TriNetX to help these innovators address unmet needs and achieve new breakthroughs in combating diseases and improving patient outcomes.”
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,100 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.
TriNetX is the global health research network enabling healthcare organizations, biopharma and contract research organizations (CROs) to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. Each member of our community shares in the consolidated value of our global, federated health research network that connects clinical researchers in real-time to the patient populations which they are attempting to study. For more information, visit http://www.trinetx.com.